This story was updated following CVS Health's earnings call Wednesday morning. | The company reported improvements in its ...

CVS Health raised its annual adjusted profit forecast on Wednesday, aided by improved pharmacy revenues, but also announced a $5.73 billion writedown of healthcare businesses including its in-pharmacy ...

CVS Health management raised 2025 EPS guidance, projecting robust double-digit earnings growth. Click here to read why CVS stock is a Buy.

CVS Caremark, the largest PBM in the U.S., tells activists Gilead needs to lower the price of its new HIV drug to get on ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style ...

Worth noting, CVS Caremark—the biggest PBM in the U.S.— announced in May that it would make Novo Nordisk’s rival drug Wegovy ...

Philadelphia has sued major pharmacy benefit managers, alleging their marketing and distribution of opioids contributed to ...

DeVaney will lead CVS’ pharmacy benefit manager after roughly two months in the interim role, the healthcare giant said in a Monday press release. Before serving as interim president at Caremark, ...

A federal judge has ordered CVS Health’s pharmacy benefit manager, Caremark, to pay nearly $290 million after a whistleblower accused the business of overcharging Medicare on prescription drugs more ...

CVS Caremark, the pharmaceutical subsidiary of CVS Health, announced Wednesday it will replace AbbVie’s Humira from its list of covered drugs with cheaper alternatives for some customers—a move that’s ...

The specialty grocer, which spends millions each year on insulin for employees, accused the companies of profiting from ...